Breakthrough optical technology to assess colon cancer risk, accuracyOctober 02, 2008Researchers at NorthShore University HealthSystem (NorthShore) and Northwestern University have discovered that fiber optic technology can for the very first time effectively measure blood levels in the colonic lining (mucosa) in humans, thus having potential applications for analyzing risk of colon cancer. The study appears in the October 2008 issue of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. The study used fiber optic technology to map microvascular blood content in patients during colonoscopy. The results provide the first indication that the early increase in blood supply (EIBS) is detectable in humans and that a high blood level mirrors proximity to neoplasia (process of tumor formation). The findings also suggest that this technology could be a valuable screening tool for enhancing polyp detection and could lead to improvements in colon cancer prevention. "Our premise is that since the lining of the large intestine -- rectum and colon -- is contiguous, if you see an abnormality in one part of the colon, then somewhere else in the colon you have a higher likelihood of harboring an adenoma [benign tumor] or carcinoma [malignant tumor]," said Hemant K. Roy, M.D., director of gastroenterology research at NorthShore University HealthSystem and the study's principal clinical researcher. "EIBS strengthens our premise thanks largely to the unique and accurate ability of Four Dimensional Elastic Light Scattering Fingerprinting (4D-ELF)." This state-of-the-art light probe was developed by Vadim Backman, professor of biomedical engineering at Northwestern University's McCormick School of Engineering and Applied Science. It utilizes a revolutionary light scattering technology that can detect subtle abnormal changes in cells lining the colon long before those changes can be seen under a microscope, and even before polyps form. "It's fascinating," said Roy, "to very precisely know that you're looking at the most superficial layer of tissue -- which is where all polyps and cancer start -- and the accuracy with which these things can be measured." Researchers used the optic probe to measure oxygenated (Ohb) and deoxygenated (Dhb) hemoglobin (Hb) specifically in the colonic lining where small blood vessels circulate. At NorthShore's Evanston Hospital, 222 patients undergoing colonoscopy screening were recruited for the study in 2006 and 2007. Of these patients, 175 had no adenomas detected, 35 had non-advanced adenomas and 12 had advanced adenomas (polyps larger than one centimeter). The mean age was 56.6 years and 40 percent were female. There were no significant differences in gender. The groups did not significantly differ in tobacco or alcohol history. The study found that the total Hb concentration was elevated 75.3 percent above control levels (comparable region from patients with no adenomas) at the adenoma site and persisted in the uninvolved mucosa (microscopically normal) area. Moreover, tissue sites located within 10 and 30 centimeters away from an adenoma also manifested a highly statistically significant increase in total Hb, OHb and DHb concentration. "We are not determining whether an abnormality is cancer or not cancer," said Roy. "What we are doing is using optical technology to determine if we can assess risk through looking at field carcinogenesis [cancer formation]. The potential clinical applications include enhanced polyp detection during colonoscopy." "While the technology is still in the clinical trial phase," notes Michael Goldberg, M.D., head of gastroenterology at NorthShore University HealthSystem, "it could be available to patients at NorthShore in five years." Colon cancer is the second-leading cause of cancer death in the United States, killing 55,000 Americans each year. The disease is 90 percent preventable if pre-cancerous polyps are detected early and removed. "This partnership with Dr. Backman at Northwestern University has the potential of bringing a suite of technologies that is not meant to replace colonoscopy," said Roy, "but rather to more precisely determine risk and thereby help to individualize recommendations on the timing of colonoscopy for colon cancer screening. This improved efficiency and accuracy may aid in cancer prevention efforts." Northwestern University |
|||||||||||||||||||||
| Related Colonoscopy Current Events and Colonoscopy News Articles Colon cancer screening more effective earlier in day, UCLA study finds The effectiveness of a screening colonoscopy may depend on the time of day it is performed. According to a new UCLA study, early-morning colonoscopies yielded more polyps per patient than later screenings, and fewer polyps were found hour by hour as the day progressed. Residents play key role in CT colonography awareness and promoting the radiology specialty Residents can serve a vital role in educating Congress, the medical community, and the general public regarding the efficacy of cutting-edge technologies like CT colonography (CTC) as well as the importance of radiologists' training and education and the role that radiologists serve in the provision of quality health care. High-definition Colonoscopy Detects More Polyps, Mayo Clinic Researchers Say High-definition (HD) colonoscopy is much more sensitive than standard colonoscopy in finding polyps that could morph into cancer, say researchers at the Mayo Clinic campus in Florida. Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients. M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers. How to Lower Costs, Waiting Times for Colonoscopies Colorectal cancer is a leading cause of cancer-related deaths in the United States, leading to over 50,000 fatalities every year. New blood tests promise simple, cost-effective diagnosis of gastrointestinal cancers Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers will be presented at Europe's largest cancer congress. Gut Ecology in Transplant Patients Small-bowel transplant patients with an ileostomy -- an opening into their small bowel -- have a very different population of bacteria living in their gut than patients whose ileostomy has been closed, researchers from UC Davis and Georgetown University Medical Center have found. How to increase colonoscopy attendance? In view of low attendance rate for colonoscopy screening for colorectal cancer (CRC), it is necessary to establish effective intervention methods to increase colonoscopy compliance. Reinterpretation of proximal colon polyps called hyperplastic in 2001 Serrated colorectal polyps include the subgroups hyperplastic polyps, sessile serrated polyps (also called sessile serrated adenomas), and serrated adenomas. More Colonoscopy Current Events and Colonoscopy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||